This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Sanofi Pasteur Inc., Sk Bioscience Co., Ltd., Sk Bioscience Co., Ltd.. Active years: 2021-2026.
Company Filing History:
6 out of 168 
5 out of 13 
1 out of 2 Years Active: 2021-2026
Title: The Innovations of Robert Hopfer: A Pioneer in Pneumococcal Vaccines
Introduction
Robert Hopfer, an accomplished inventor located in Roaring Brook Township, Pennsylvania, has made significant contributions to the field of immunology. With a noteworthy portfolio of five patents, he has focused primarily on the development of multivalent pneumococcal polysaccharide-protein conjugate compositions that enhance vaccine efficacy in combating bacterial infections.
Latest Patents
Among his latest innovations are two prominent patents for multivalent pneumococcal polysaccharide-protein conjugate compositions. The first patent describes a mixed carrier composition that includes 21 different pneumococcal capsular polysaccharide-protein conjugates. Each of these conjugates includes a capsular polysaccharide from various serotypes that are conjugated either to tetanus toxoid (TT) or CRM. The selected serotypes provide a broad defense against diseases caused by pneumococcus. The second patent describes a similar composition with 20 different pneumococcal capsular polysaccharide-protein conjugates, detailing the conjugation methods and applications for prophylaxis against associated infections or diseases.
Career Highlights
Robert has held significant positions at notable companies such as Sanofi Pasteur Inc. and SK Bioscience Co., Ltd. His work in these organizations has contributed to advancements in vaccine technology, specifically in the realm of pneumococcal disease prevention. His innovative approaches to vaccine development establish him as a forward-thinking inventor in the healthcare sector.
Collaborations
Throughout his career, Robert has collaborated with skilled colleagues, including Kyungjun An and Dongsoo Ham. These partnerships have fostered a creative environment conducive to groundbreaking research and development in immunological applications.
Conclusion
Robert Hopfer's dedication to advancing the field of vaccines, particularly through his innovative compositions for pneumococcal infections, underlines his significance as a leading inventor. With a foundation built on collaboration and research, he continues to influence the health sector positively, paving the way for improved preventive measures against bacterial diseases.